title: Current and future approaches to ensure the viral safety of biopharmaceuticals.
authors.affiliation: Division of Monoclonal Antibodies, CDER/FDA, Bethesda, MD 20892, USA. kurt.brorson@fda.hhs.gov
authors.forename: K
authors.initials: K
authors.lastname: Brorson
authors.forename: L
authors.initials: L
authors.lastname: Norling
authors.forename: E
authors.initials: E
authors.lastname: Hamilton
authors.forename: S
authors.initials: S
authors.lastname: Lute
authors.forename: K
authors.initials: K
authors.lastname: Lee
authors.forename: S
authors.initials: S
authors.lastname: Curtis
authors.forename: Y
authors.initials: Y
authors.lastname: Xu
mesh_terms: D000818:Animals; D001688:Biological Products / Q000302:isolation & purification* / Q000592:standards*; D001702:Biopharmaceutics / Q000592:standards; D005374:Filtration; D006801:Humans; D016133:Polymerase Chain Reaction; D012449:Safety; D014481:United States; D014780:Viruses / Q000235:genetics / Q000302:isolation & purification*
chemical_list: D001688:Biological Products